238 related articles for article (PubMed ID: 31205227)
41. An Acquired and Endogenous Glycocalyx Forms a Bidirectional "Don't Eat" and "Don't Eat Me" Barrier to Phagocytosis.
Imbert PRC; Saric A; Pedram K; Bertozzi CR; Grinstein S; Freeman SA
Curr Biol; 2021 Jan; 31(1):77-89.e5. PubMed ID: 33096038
[TBL] [Abstract][Full Text] [Related]
42. Metabolic rewiring of macrophages by CpG potentiates clearance of cancer cells and overcomes tumor-expressed CD47-mediated 'don't-eat-me' signal.
Liu M; O'Connor RS; Trefely S; Graham K; Snyder NW; Beatty GL
Nat Immunol; 2019 Jan; 20(3):265-275. PubMed ID: 30664738
[TBL] [Abstract][Full Text] [Related]
43. The CD47-SIRPα signaling axis as an innate immune checkpoint in cancer.
Matlung HL; Szilagyi K; Barclay NA; van den Berg TK
Immunol Rev; 2017 Mar; 276(1):145-164. PubMed ID: 28258703
[TBL] [Abstract][Full Text] [Related]
44. "Velcro" engineering of high affinity CD47 ectodomain as signal regulatory protein α (SIRPα) antagonists that enhance antibody-dependent cellular phagocytosis.
Ho CC; Guo N; Sockolosky JT; Ring AM; Weiskopf K; Özkan E; Mori Y; Weissman IL; Garcia KC
J Biol Chem; 2015 May; 290(20):12650-63. PubMed ID: 25837251
[TBL] [Abstract][Full Text] [Related]
45. CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy.
Barkal AA; Brewer RE; Markovic M; Kowarsky M; Barkal SA; Zaro BW; Krishnan V; Hatakeyama J; Dorigo O; Barkal LJ; Weissman IL
Nature; 2019 Aug; 572(7769):392-396. PubMed ID: 31367043
[TBL] [Abstract][Full Text] [Related]
46. CD47 Blockade Inhibits Tumor Progression through Promoting Phagocytosis of Tumor Cells by M2 Polarized Macrophages in Endometrial Cancer.
Gu S; Ni T; Wang J; Liu Y; Fan Q; Wang Y; Huang T; Chu Y; Sun X; Wang Y
J Immunol Res; 2018; 2018():6156757. PubMed ID: 30525058
[TBL] [Abstract][Full Text] [Related]
47. Putting the brakes on phagocytosis: "don't-eat-me" signaling in physiology and disease.
Kelley SM; Ravichandran KS
EMBO Rep; 2021 Jun; 22(6):e52564. PubMed ID: 34041845
[TBL] [Abstract][Full Text] [Related]
48. BRAF/MEK inhibitors promote CD47 expression that is reversible by ERK inhibition in melanoma.
Liu F; Jiang CC; Yan XG; Tseng HY; Wang CY; Zhang YY; Yari H; La T; Farrelly M; Guo ST; Thorne RF; Jin L; Wang Q; Zhang XD
Oncotarget; 2017 Sep; 8(41):69477-69492. PubMed ID: 29050218
[TBL] [Abstract][Full Text] [Related]
49. A single-valent long-acting human CD47 antagonist enhances antibody directed phagocytic activities.
Wu F; Qiu Y; Xu Y
Cancer Immunol Immunother; 2020 Dec; 69(12):2561-2569. PubMed ID: 32583154
[TBL] [Abstract][Full Text] [Related]
50. HIV-1 Vpu Promotes Phagocytosis of Infected CD4
Cong L; Sugden SM; Leclair P; Lim CJ; Pham TNQ; Cohen ÉA
mBio; 2021 Aug; 12(4):e0192021. PubMed ID: 34425695
[TBL] [Abstract][Full Text] [Related]
51. CD47 expression attenuates Ebola virus-induced immunopathology in mice.
Rao D; O'Donnell KL; Carmody A; Weissman IL; Hasenkrug KJ; Marzi A
Antiviral Res; 2022 Jan; 197():105226. PubMed ID: 34923028
[TBL] [Abstract][Full Text] [Related]
52. CD47-SIRPα blocking-based immunotherapy: Current and prospective therapeutic strategies.
Bouwstra R; van Meerten T; Bremer E
Clin Transl Med; 2022 Aug; 12(8):e943. PubMed ID: 35908284
[TBL] [Abstract][Full Text] [Related]
53. Engineered proteins with sensing and activating modules for automated reprogramming of cellular functions.
Sun J; Lei L; Tsai CM; Wang Y; Shi Y; Ouyang M; Lu S; Seong J; Kim TJ; Wang P; Huang M; Xu X; Nizet V; Chien S; Wang Y
Nat Commun; 2017 Sep; 8(1):477. PubMed ID: 28883531
[TBL] [Abstract][Full Text] [Related]
54. Galectin-3 Cooperates with CD47 to Suppress Phagocytosis and T-cell Immunity in Gastric Cancer Peritoneal Metastases.
Fan Y; Song S; Li Y; Dhar SS; Jin J; Yoshimura K; Yao X; Wang R; Scott AW; Pizzi MP; Wu J; Ma L; Calin GA; Hanash S; Wang L; Curran M; Ajani JA
Cancer Res; 2023 Nov; 83(22):3726-3738. PubMed ID: 37738407
[TBL] [Abstract][Full Text] [Related]
55. Blocking the CD47-SIRPα interaction reverses the disease phenotype in a polycythemia vera mouse model.
Lysenko V; Schürch PM; Tuzlak S; van Wijk NW; Kovtonyuk LV; Becher B; Manz MG; Kreutmair S; Theocharides APA
Leukemia; 2023 Jun; 37(6):1277-1286. PubMed ID: 37095207
[TBL] [Abstract][Full Text] [Related]
56. The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors.
Willingham SB; Volkmer JP; Gentles AJ; Sahoo D; Dalerba P; Mitra SS; Wang J; Contreras-Trujillo H; Martin R; Cohen JD; Lovelace P; Scheeren FA; Chao MP; Weiskopf K; Tang C; Volkmer AK; Naik TJ; Storm TA; Mosley AR; Edris B; Schmid SM; Sun CK; Chua MS; Murillo O; Rajendran P; Cha AC; Chin RK; Kim D; Adorno M; Raveh T; Tseng D; Jaiswal S; Enger PØ; Steinberg GK; Li G; So SK; Majeti R; Harsh GR; van de Rijn M; Teng NN; Sunwoo JB; Alizadeh AA; Clarke MF; Weissman IL
Proc Natl Acad Sci U S A; 2012 Apr; 109(17):6662-7. PubMed ID: 22451913
[TBL] [Abstract][Full Text] [Related]
57. TTI-621 (SIRPαFc): A CD47-Blocking Innate Immune Checkpoint Inhibitor with Broad Antitumor Activity and Minimal Erythrocyte Binding.
Petrova PS; Viller NN; Wong M; Pang X; Lin GH; Dodge K; Chai V; Chen H; Lee V; House V; Vigo NT; Jin D; Mutukura T; Charbonneau M; Truong T; Viau S; Johnson LD; Linderoth E; Sievers EL; Maleki Vareki S; Figueredo R; Pampillo M; Koropatnick J; Trudel S; Mbong N; Jin L; Wang JC; Uger RA
Clin Cancer Res; 2017 Feb; 23(4):1068-1079. PubMed ID: 27856600
[No Abstract] [Full Text] [Related]
58. BNIP3 modulates the interface between B16-F10 melanoma cells and immune cells.
Romano E; Rufo N; Korf H; Mathieu C; Garg AD; Agostinis P
Oncotarget; 2018 Apr; 9(25):17631-17644. PubMed ID: 29707136
[TBL] [Abstract][Full Text] [Related]
59. CD47 Expression Defines Efficacy of Rituximab with CHOP in Non-Germinal Center B-cell (Non-GCB) Diffuse Large B-cell Lymphoma Patients (DLBCL), but Not in GCB DLBCL.
Bouwstra R; He Y; de Boer J; Kooistra H; Cendrowicz E; Fehrmann RSN; Ammatuna E; Zu Eulenburg C; Nijland M; Huls G; Bremer E; van Meerten T
Cancer Immunol Res; 2019 Oct; 7(10):1663-1671. PubMed ID: 31409608
[TBL] [Abstract][Full Text] [Related]
60. CD47 in Erythrocyte Ageing and Clearance - the Dutch Point of View.
Burger P; de Korte D; van den Berg TK; van Bruggen R
Transfus Med Hemother; 2012 Oct; 39(5):348-52. PubMed ID: 23801927
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
